Víctor Urrea Gales
Víctor Urrea Gales was awarded an MSc in Statistics and Operations Research by the Technical University of Catalonia (UPC) in 2009 and a PhD in Systems Biology by the University of Vic (UVic) in 2015. His research focuses on the development of new methods to study genetic interactions, the identification of genetic risk profiles and the construction of disease prediction and prognostic models. Employed as a statistician at IrsiCaixa, he assists in the analysis of experimental and clinical trial data.
Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS-CoV-2 mRNA-1237 vaccine in patients with solid tumors.
Remodeling the bladder tumor immune microenvironment by mycobacterial species with changes in their cell envelope composition.
Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study.
Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4+ T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy.
Switching From a Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy-suppressed Human Immunodeficiency Virus-infected Individuals.